Cardiology

A new study sheds light on the impact of statins and metformin use on risk of death in prostate cancer patients.

Caption Guidance can be used by providers with or without prior ultrasound experience.

An analysis of the MESA study is shedding light on the potential association between having persistent asthma and developing atrial fibrillation.

New study using data obtained through wearables found resting heart rate can vary by up to 70 beats per minute from patient to patient.

What does a strong physician-patient connection look like in 2020?

Physically active geriatric adults are generally healthier physically and mentally than inactive older adults.

Screening, testing and counseling for marijuana use is needed, especially in young patients presenting with cardiovascular disease, according to a review recently published in the Journal of the American College of Cardiology.

Coronary microvascular dysfunction is independently related to abnormal cardiac mechanics, according to a new study.

A cardiologist and professor of medicine at Duke discusses the nuances of approaching stroke prevention in obese patients compared to those with other risk factors.

The CATALYST trial will examine use of the Amplatzer Amulet Left Atrial Appendage Occluder in more than 2500 patients with AFib at risk of stroke.

Results of an analysis incorporating data on more than 29,000 patients concluded consuming 2 or more servings of meat per week increased risk of cardiovascular disease.

Investigators link waist circumference with an increased risk of depression for patients with arterial stiffness.

A meta-analysis of CREDENCE, DECLARE-TIMI 58, CANVAS, and EMPA-REG OUTCOME trial is revealing more about how SGLT2 inhibition impacts different subgroups of diabetics.

A new analysis of more than 15,000 Europeans found bariatric surgery could reduce all-cause mortality and heart failure.

Investigators report a positive incremental net monetary benefit of nearly $6800 when patients with heart failure use a telehealth solution.

An analysis of the Southern Community Cohort Study found differences in the impact of modifiable risk factors for heart failure among black and white patients.

The remote patient monitoring platform delivers data directly to the physician and reduces hospitalizations and emergency department trips.

Compared with other antihypertensive medications, amlodipine was found to reduce risk of gout in older patients.

An oral tablet combining empagliflozin, linagliptin, metformin hydrochloride will soon be available on US markets.

New data from the Annual Meeting of the Society of Thoracic Surgeons reveals a three-day stay is not associated with increased risk of worse outcomes or readmission.

A new analysis of more than 125,000 found no differences in mortality or MACE based on type of insulin used.

New data suggests sacubitril/valsartan could reduce risk of hospitalization and mortality in HFrEF patients when compared with ACEs/ARBs.

A new review of more than a dozen studies is breaking down racial differences in diagnosis, treatment, and outcomes of severe aortic stenosis.

Functional disability or death rates 3 months following intracerebral hemorrhage are notably less among 2 minority groups.

A new study is warning a common practice when it comes to recording blood pressure could be ignoring a potential warning sign for risk later in life.

Blood pressure irregularities start early for women and progress more rapidly than in men, eventually leading to cardiovascular disease later in life, researchers report in JAMA Cardiology.

A new review in the Journal of the American College of Cardiology is highlighting the impact of marijuana use on heart health.

Analysis of more than 20,000 individuals found excess belly fat—measured by waist circumference—was linked to a significantly increased risk for suffering recurrent ASCVD events.

The latest episode of the DocTalk Podcast features Tsuyoshi Kaneko, MD, of Brigham and Women's Hospital, discussing the most recent data and trends in transcatheter aortic valve replacement.

The GLP-1 agonist now has indications for the reduction of MACE and the management of A1C in patients with type 2 diabetes.